Dr Katriona Brooksbank holds a BSc (Hons) in Genetics (Immunology) and a PhD in Medicine and Therapeutics from the University of Aberdeen.
With experience spanning academia, industry, and the health service both in the UK and internationally, Katriona has specialised in the ethical design and delivery of observational health research and clinical trials, as well as innovation and technology evidence generation in healthcare. To complement her postdoctoral work in novel therapeutics—including digital solutions and AI as a medical device—she completed a Master of Laws in Medical Law and Ethics.
Currently, Katriona is the R&I Innovation Lead for WosIH (core CSO funded), supporting innovation across Health Boards in the West of Scotland and collaborating closely with colleagues in the North and East of Scotland. She is Co-Chair of the AI Governance Group, a member of the National Steering Committee for AI deployment, and Chair of the Health Research Authority Research Ethics Committee (WoSREC1).
As Intellectual Property Officer at NHSGGC, she supports benefit sharing with partners. Katriona is also an Honorary Associate Professor at the University of Glasgow, teaching and directing the MSc in MedTech Innovation and leading courses on ethics, regulation, and governance.
Ana-Zeralda Canals Hamann is an Associate Director in Clinical Trial Supplies & CMC Project Leader at Debiopharm International SA based in Lausanne, Switzerland. A clinical supply chain leader with over 15 years of experience, she specializes in CMC, logistics, and operations within complex, international biopharmaceutical environments.
She has a proven record of building global clinical supply strategies across multiple therapeutic areas, including oncology and rare diseases. Her operational expertise spans GxP/GMP/GDP compliance, digitalization, sustainability, and Lean transformation. She is actively involved in the industry as a Committee Member and former Chair of the European Global Clinical Supplies Group (GCSG) and serves on the Research Ethics Committee at Queen Mary University of London.
Amanda Briceno is an experienced clinical supply professional with over 10 years in clinical research and supply chain operations. Originally from Venezuela, now based in Italy. She currently serves as Clinical Supply Manager and Head of the Patient Centricity Unit at Chiesi Farmaceutici, where she leads initiatives to design and deliver patient-focused clinical supply solutions that improve trial compliance and enhance the experience of both patients and site staff.
Her career began as a Clinical Research Associate at IQVIA, where she gained extensive experience in global trial monitoring and operations. Since joining Chiesi, Amanda has held positions of increasing responsibility within the Clinical Supply department, before assuming her current leadership role.
Amanda holds a Master’s degree in Drug Biotechnology from the Università degli Studi di Milano and a Bachelor’s degree in Medical Biotechnology. Amanda brings a strong blend of technical knowledge and operational leadership. Passionate about innovation in clinical supplies, she is dedicated to advancing more accessible, patient-centric clinical trials.
